Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Robotic chair eases back pain in new trial

NCT ID NCT06662032

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a robotic device called LumbaCure that gently moves the lower back to help people with chronic low back pain. 50 adults used the device for 15 minutes during their regular exercise sessions. The goal was to see if it reduces disability and pain better than exercise alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Jun 2024

Finished

Jun 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Chronic non-specific LBP (without red flag) * LBP is the principal musculoskeletal condition * Aged between 18 and 85 years old * Able to read and understand questionnaires and communicate with the physiotherapist. * Average Back Pain intensity over the last week above 2, assessed on Numerical Pain Rating Scale from 0 to 10 anchored with "no pain" at 0 and "worst pain imaginable " at 10. Exclusion Criteria: * Suspected or confirmed serious pathology (i.e infection, fracture, cancer, inflammatory arthritis, ….) * Significant sciatica VAS \> 7 * Radiculopathy * Cognitive impairment that precludes participant from consenting, completing investigation questionnaires or complying with recommendations * Previous spine surgery in the last 3 months * Pregnant women * body weight \> 120 kg * Neurological disease * Fibromyalgia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic low back pain (CLBP) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Jessa Ziekenhuis

    Hasselt, Belgium

  • Jessa Ziekenhuis

    Herk-de-Stad, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.